Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis 2096

Max Ratio

Dividend Yield

2.47 %

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

46.02 %

Dividend History 2096

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 2.47 %
Consecutive Years 0
Forward Annual Dividend 0.35 HKD
Consistent Years 0
Dividend CAGR 3Y -0.86 %
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM 56.49 %
Dividend CAGR 10Y
Ex Dividend Date 06/18/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth 2096

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin 2096

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income 2096

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM 2096

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio 2096

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Simcere Pharmaceutical Group Ltd 2096

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself 2096

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 35.18
Forward PE 13.44
Enterprise Value Revenue 4.43
Price Sales TTM 5.01
Enterprise Value EBITDA 29.07
Price Book MRQ 4.55

Simcere Pharmaceutical Group Ltd Dividends: 1.23 % Yield, History, Payment Schedule

2096
Current price
14.17 HKD +0.53 HKD (+3.89%)
Last closed 13.64 HKD
ISIN HK0000658531
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Hong Kong Stock Exchange
Capitalization 35 610 235 567 HKD
Yield for 12 month +94.11 %
1Y
3Y
5Y
10Y
15Y
2096
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+6 634 701 347 HKD

Last Year

+6 607 297 452 HKD

Current Quarter

+1 760 708 246 HKD

Last Quarter

+1 760 708 246 HKD

Current Year

+5 324 170 019 HKD

Last Year

+4 983 770 169 HKD

Current Quarter

+1 431 213 562 HKD

Last Quarter

+1 431 213 562 HKD
EBITDA 1 484 915 954 HKD
Operating Margin TTM 19.93 %
Price to Earnings 35.18
Return On Assets TTM 6.50 %
PEG Ratio
Return On Equity TTM 12.45 %
Wall Street Target Price 122.99 HKD
Revenue TTM 7 106 053 052 HKD
Book Value 2.92 HKD
Revenue Per Share TTM
Dividend Share 0.16 HKD
Quarterly Revenue Growth YOY 15.10 %
Dividend Yield 2.47 %
Gross Profit TTM 5 756 054 738 HKD
Earnings per share 0.47 HKD
Diluted Eps TTM 0.47 HKD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY 38.10 %
Profit Margin 12.39 %

Technical Indicators 2096

For 52 Weeks

6.10 HKD 15.08 HKD
50 Day MA 13.00 HKD
Shares Short Prior Month
200 Day MA 10.77 HKD
Short Ratio
Shares Short
Short Percent